Profil
Andrew James McLean is currently a Non-Executive Director at Vaccitech (UK) Ltd. and a Director at Theolytics Ltd. He was previously a Director at Argonaut Therapeutics Ltd. and a Director at Osler Diagnostics Ltd. from 2016 to 2019.
Aktiva positioner av Andrew James McLean
| Företag | Position | Start |
|---|---|---|
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Direktör/Styrelseledamot | - |
Theolytics Ltd.
Theolytics Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Andrew James McLean
| Företag | Position | Slut |
|---|---|---|
Osler Diagnostics Ltd.
Osler Diagnostics Ltd. BiotechnologyHealth Technology Engages in research and development in biotechnology | Direktör/Styrelseledamot | 2019-12-31 |
Argonaut Therapeutics Ltd.
Argonaut Therapeutics Ltd. BiotechnologyHealth Technology Develops epigenetically-acting drugs which target abnormal arginine methylation in cancer | Direktör/Styrelseledamot | 2019-10-09 |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Theolytics Ltd.
Theolytics Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Argonaut Therapeutics Ltd.
Argonaut Therapeutics Ltd. BiotechnologyHealth Technology Develops epigenetically-acting drugs which target abnormal arginine methylation in cancer | Health Technology |
Osler Diagnostics Ltd.
Osler Diagnostics Ltd. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
















